October 5, 2020

CDC Recognizes and Codifies CLI and CLTI in ICD-10-CM

October 5, 2020—A coalition organized by the CLI Global Society announced that its proposal to distinctly recognize “critical limb ischemia” (CLI) and “chronic limb-threatening ischemia” (CLTI) in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) was approved by the Centers for Disease Control and Prevention and went into effect October 1.

According to the announcement, the CLI Global Society was established in 2016 to address the unmet need of CLI. The intent of the society is to work toward a coalition of global organizations that share an interest in CLI to facilitate the implementation of goals that will lead to ideal management of this impactful problem to improve quality of life and longevity of patients by preventing amputations and death due to CLI.

The goal of this initiative is to support coding professionals, educators, compliance staff, and physicians to identify and accurately report CLI and CLTI in clinical documentation, electronic medical records, and medical billing to track and monitor patient treatments and outcomes in the future.

The CLI Global Society worked in close partnership with the vascular specialist community to develop the proposal. Coalition members include:

  • Robert Lookstein, MD, CLI Global Society
  • Barry T. Katzen, MD, CLI Global Society
  • Sean Roddy, MD, Society for Vascular Surgery
  • Mitchell Weinberg, MD, Society for Vascular Medicine
  • Bulent Arslan, MD, Society of Interventional Radiology
  • Mehdi Shishehbohr, DO, of Society for Cardiovascular Angiography and Intervention

“This effort is a first step in building awareness of the complexity associated with caring for patients [with] CLI within public and commercial payers and the broader health care community,” commented Dr. Katzen, Board Chair of the CLI Global Society. “These dedicated codes, now newly identified for CLI, are critical in our goal to improve quality of life by preventing amputations and death due to CLI.”

Dr. Lookstein, Chair of the Vascular Societies Workgroup and CLI Global Society board member, acknowledged the collective effort of his colleagues, “who came together to prioritize the need for a well-defined and accessible method to identify, report, and track CLI for the benefit of patients [with] this disease."

He explained, “We also look forward to continued partnership as we launch initiatives to educate our membership, our hospitals, and health care provider staff regarding these changes. They have the potential to positively impact the care we provide to these extremely vulnerable patients across the United States and around the world.”

“The statistics are grim,” stated Jihad Mustapha, MD, founding board member of the CLI Global Society. “We know 60% of patients who receive an amputation due to peripheral artery disease or CLI die within 2 years—this is higher than the 5-year mortality rate for patients with breast, colon, and prostate cancer. In order to fight this deadly disease, we need to have accurate data. This seemingly small change to medical coding will allow us to save countless limbs—and lives.”


October 6, 2020

PQ Bypass Completes Enrollment in DETOUR2 Study and Names Heather Simonsen as President

October 1, 2020

Funding Supports Clinical Studies of Alucent Biomedical’s Vessel Restoration System